Elizabeth de Somer


Elizabeth de Somer

Elizabeth de Somer has over 20 years’ experience in health care and pharmaceutical health policy including drug development, clinical research, manufacturing, drug safety, regulatory affairs, and medicines and vaccines health policy. 

Elizabeth also contributes her clinical and industry expertise to a number of expert committees providing advice to Government, including representing the industry on the sub-committees to the Pharmaceutical Benefits Advisory Committee (PBAC) [the Economic Sub-Committee ESC and Drug Utilisation Sub-Committees DUSC].

Elizabeth's academic qualifications lie in medical sciences and drug development, which lead her to provide occasional lectures on drug development, regulation of medicines, quality use of medicines and the policy environment affecting access to medicines in Australia.

Elizabeth is the Chief Executive Officer at Medicines Australia, the peak body representing research based pharmaceutical companies in Australia, where she leads collaboration with government and the development of sound policies to support access to prescription medicines for Australian patients.